TARDBP and amyotrophic lateral sclerosis: Cryptic peptides, closely linked to TDP-43 pathology, are emerging biomarkers expressed in CFS, plasma, and serum, with strong potential for early, pathology-specific ALS diagnosis and patient subtyping.